These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7549614)

  • 21. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Grados MA; Ginsburg GS; Drake KL; Kingery JN
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):573-574. PubMed ID: 19395904
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of clomipramine in obsessive-compulsive disorder.
    Howland RH
    Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-selective effects of selective serotonin reuptake inhibitors.
    Zurowski B; Kordon A; Wahl K; Hohagen F
    Biol Psychiatry; 2008 Jan; 63(1):e5; author reply e7. PubMed ID: 17693390
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
    Aggarwal A; Jain M; Garg A; Jiloha RC
    Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
    [No Abstract]   [Full Text] [Related]  

  • 25. One year follow-up of postpartum-onset obsessive-compulsive disorder: a case series.
    Uguz F; Kaya N; Sahingoz M; Cilli AS; Akman C
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1091-2. PubMed ID: 18400352
    [No Abstract]   [Full Text] [Related]  

  • 26. Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.
    Corregiari FM; Bernik M; Cordeiro Q; Vallada H
    Clinics (Sao Paulo); 2012; 67(4):335-40. PubMed ID: 22522758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Obsessive-compulsive symptoms in schizophrenia: remission with anti-obsessive treatment].
    Payá González B; Crespo Facorro B; Sáenz Herrero M; Ayuso Gutiérrez JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):201-3. PubMed ID: 9717345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.
    Kayser RR
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926602
    [No Abstract]   [Full Text] [Related]  

  • 30. Obsessive-compulsive disorder-related disorders: the role of selective serotonergic reuptake inhibitors.
    Hollander E
    Int Clin Psychopharmacol; 1996 Dec; 11 Suppl 5():75-87. PubMed ID: 9032004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond depression: citalopram for obsessive-compulsive disorder.
    Pato MT
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S19-26. PubMed ID: 10471169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tourette syndrome. Medical and surgical treatment of obsessive-compulsive disorder.
    Rapoport JL; Inoff-Germain G
    Neurol Clin; 1997 May; 15(2):421-8. PubMed ID: 9115472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder.
    Owley T; Owley S; Leventhal B; Cook EH
    J Child Adolesc Psychopharmacol; 2002; 12(2):165-71. PubMed ID: 12188985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of obsessive-compulsive disorder in an adult].
    Kähkönen S; Holmberg N
    Duodecim; 2010; 126(11):1310-6. PubMed ID: 20681354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder.
    Farnam A; Goreishizadeh MA; Farhang S
    Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Obsessive compulsive disorder (OCD)].
    Debabèche C; Muselle A; Servais S; Farcy L; Barbier V; Laloyaux C; Mikolajczak G; Desseilles M
    Rev Med Suisse; 2009 Aug; 5(214):1659-62. PubMed ID: 19772197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venlafaxine treatment of obsessive-compulsive disorder: case reports.
    Marazziti D
    CNS Spectr; 2003 Jun; 8(6):421-2. PubMed ID: 12858131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are SSRIs effective for treating OCD?
    Kripke C
    Am Fam Physician; 2008 May; 77(9):1252. PubMed ID: 18540489
    [No Abstract]   [Full Text] [Related]  

  • 40. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.